A major clinical trial has shown that by using MRI and tracking to guide the delivery of magnetic stimulation to the brains of people with severe depression, patients will see their symptoms ease for at least six months, ...
Jan 16, 2024
0
51
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, University of East London (UEL) and the University of Pennsylvania has used artificial intelligence to analyze the ...
Jan 12, 2024
0
40
A recent study published in Molecular Psychiatry has identified previously unknown alterations in neural connectivity that promote psychomotor disturbance—a slowing or reduction in movement—in individuals with major depressive ...
Jan 11, 2024
0
28
Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how these effects arise is ...
Jan 10, 2024
0
103
Symptom burden during repetitive transcranial magnetic stimulation (rTMS) treatment for major depressive disorder (MDD) may be most accurately assessed through the use of multiple instruments, according to a study published ...
Dec 29, 2023
0
15
A pilot clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found electrical stimulation of the spinal cord is feasible, well-tolerated and shows therapeutic potential to treat depression.
Dec 20, 2023
0
72
Results from a Phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psilocybe, may benefit individuals with cancer and major depression. Trial participants treated ...
Dec 18, 2023
0
249
Major depressive disorder affects 16.1 million adults in the United States and costs $210 billion annually. While the primary symptoms of depression are psychological, scientists and doctors have come to understand that depression ...
Dec 15, 2023
1
77
There is nothing magic about the recent increase in interest around the study of psychedelic drugs as potential treatments for patients suffering from a myriad of mental health conditions.
Dec 15, 2023
0
33
Maryam Shanechi, Dean's Professor of Electrical and Computer Engineering and Founding Director of the USC Center for Neurotechnology, and her Ph.D. students have developed a new, advanced deep-learning method for brain signals ...
Dec 13, 2023
0
18
